<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An Internet questionnaire was used to collect data from caregivers about <z:hpo ids='HP_0001250'>seizure</z:hpo> activities and drug therapies of patients with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman's syndrome</z:e> (AS) </plain></SENT>
<SENT sid="1" pm="."><plain>A questionnaire to collect data on AS patient demographics, <z:hpo ids='HP_0001250'>seizure</z:hpo> types, laboratory diagnosis, and past history of <z:chebi fb="0" ids="35623">anticonvulsant</z:chebi> use was developed and distributed among the membership of multiple AS groups primarily through the Internet </plain></SENT>
<SENT sid="2" pm="."><plain>Caregivers of AS patients were asked to rate each drug listed on the questionnaire for its effect on the patient's behavior and alertness and on the severity and frequency of the patient's <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>A 6-point rating scale was used, with the lowest score representing the most favorable effect </plain></SENT>
<SENT sid="4" pm="."><plain>Primary considerations of the survey were to reach as many people as possible, anonymously and quickly, in a widely comprehensible format </plain></SENT>
<SENT sid="5" pm="."><plain>Data were collected between March 22 and October 9, 2002 </plain></SENT>
<SENT sid="6" pm="."><plain>Of the 88 complete questionnaires received, 75 were electronic and 13 were handwritten responses </plain></SENT>
<SENT sid="7" pm="."><plain>Forty-seven percent of respondents reported patients' use of a combination of medications at some point, with 59 different combinations described, 21 of which consisted of three or more medications </plain></SENT>
<SENT sid="8" pm="."><plain>The most commonly reported regimens were <z:chebi fb="0" ids="39867">valproic acid</z:chebi> and clonazepam, <z:chebi fb="0" ids="39867">valproic acid</z:chebi> and topiramate (with or without clonazepam), <z:chebi fb="0" ids="39867">valproic acid</z:chebi> and lamotrigine, and phenytoin and carbamazepine </plain></SENT>
<SENT sid="9" pm="."><plain>Patient characteristics and <z:hpo ids='HP_0001250'>seizure</z:hpo> types were consistent with those of AS patients described in the literature </plain></SENT>
<SENT sid="10" pm="."><plain>Topiramate and ethosuximide were rated favorably, consistent with previously published reports </plain></SENT>
<SENT sid="11" pm="."><plain>Responses to the questionnaire were widespread and rapid, with 42 responses collected in the first week </plain></SENT>
<SENT sid="12" pm="."><plain>An Internet questionnaire helped collect self-reported efficacy information from caregivers of AS patients </plain></SENT>
</text></document>